{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:35:47Z","timestamp":1790094947092,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.adro.2025.101931","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T05:14:18Z","timestamp":1761369258000},"page":"101931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adjuvant Radiation Therapy in Breast Cancer Patients With Neurofibromatosis Type 1: Safety and Long-Term Outcomes"],"prefix":"10.1016","volume":"11","author":[{"given":"Carla","family":"Benmatallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-8110","authenticated-orcid":false,"given":"Pierre","family":"Loap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2025.101931_bib0001","doi-asserted-by":"crossref","first-page":"146\u2011157","DOI":"10.1038\/labinvest.2016.142","article-title":"The NF1 gene in tumor syndromes and melanoma","volume":"97","author":"Kiuru","year":"2017","journal-title":"Lab Invest"},{"key":"10.1016\/j.adro.2025.101931_bib0002","doi-asserted-by":"crossref","first-page":"193\u2011201","DOI":"10.1634\/theoncologist.2013-0328","article-title":"Malignant peripheral nerve sheath tumors","volume":"19","author":"Farid","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.adro.2025.101931_bib0003","doi-asserted-by":"crossref","first-page":"311\u2011314","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.adro.2025.101931_bib0004","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.wneu.2017.06.010","article-title":"Radiation-induced malignant peripheral nerve sheath tumors: A systematic review","volume":"105","author":"Yamanaka","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.adro.2025.101931_bib0005","doi-asserted-by":"crossref","first-page":"481\u2011484","DOI":"10.1136\/jmg.2007.049346","article-title":"Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening","volume":"44","author":"Sharif","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.adro.2025.101931_bib0006","first-page":"vdab063","article-title":"Irradiation of Nf1 mutant mouse models of spinal plexiform neurofibromas drives pathologic progression and decreases survival","volume":"3","author":"Laurent","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.adro.2025.101931_bib0007","doi-asserted-by":"crossref","first-page":"191\u2011196","DOI":"10.1016\/0165-4608(90)90029-A","article-title":"Radiosensitivity of fibroblasts obtained from a caf\u00e9-au-lait spot and normal-appearing skin of a patient with neurofibromatosis (NF-6)","volume":"47","author":"Hannan","year":"1990","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.adro.2025.101931_bib0008","doi-asserted-by":"crossref","first-page":"120\u2011125","DOI":"10.1016\/0165-4608(93)90240-M","article-title":"Cellular radiosensitivity of patients with different types of neurofibromatosis","volume":"66","author":"Hannan","year":"1993","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.adro.2025.101931_bib0009","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.3390\/cancers14246141","article-title":"Cancer and radiosensitivity syndromes: Is impaired nuclear ATM kinase activity the primum movens?","volume":"14","author":"El Nachef","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.adro.2025.101931_bib0010","doi-asserted-by":"crossref","first-page":"3050\u20113058","DOI":"10.1200\/JCO.19.00114","article-title":"Subsequent neoplasms after a primary tumor in individuals with neurofibromatosis type 1","volume":"37","author":"Bhatia","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2025.101931_bib0011","first-page":"2127\u20112135","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2025.101931_bib0012","first-page":"1707\u20111716","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10\u2008801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.1016\/j.adro.2025.101931_bib0013","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1016\/j.annonc.2024.08.174","article-title":"231O Locoregional hypo vs normofractionated RT in early breast cancer: 5 years results of the HypoG-01 phase III UNICANCER trial","volume":"35","author":"Rivera","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2025.101931_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2025.111698","article-title":"Surgical and radiation considerations in breast cancer with neurofibromatosis type 1: A case report and literature review","volume":"134","author":"Tanaka","year":"2025","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.adro.2025.101931_bib0015","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/ijc.34057","article-title":"CANTO-RT: Skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early-stage breast cancer","volume":"151","author":"Allali","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.adro.2025.101931_bib0016","doi-asserted-by":"crossref","first-page":"1797\u20111808","DOI":"10.1002\/ijc.34664","article-title":"CANTO skin: Evaluation of skin toxicity risk factors in patients treated for breast cancer","volume":"153","author":"Allali","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.adro.2025.101931_bib0017","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.3390\/cancers13235928","article-title":"Radiodermatitis and fibrosis in the context of breast radiation therapy: A critical review","volume":"13","author":"Allali","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.adro.2025.101931_bib0018","doi-asserted-by":"crossref","first-page":"1086\u20111094","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2025.101931_bib0019","doi-asserted-by":"crossref","first-page":"3615\u20113625","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: The DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2025.101931_bib0020","doi-asserted-by":"crossref","first-page":"3604\u20113614","DOI":"10.1200\/JCO.20.01024","article-title":"Hypofractionated versus conventional fractionated radiotherapy after breast-conserving surgery in the modern treatment era: A multicenter, randomized controlled trial from China","volume":"38","author":"Wang","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2025.101931_bib0021","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.canrad.2020.07.001","article-title":"Radio-induced cardiotoxicity: From physiopathology and risk factors to adaptation of radiotherapy treatment planning and recommended cardiac follow-up","volume":"24","author":"Kirova","year":"2020","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.adro.2025.101931_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103121","article-title":"Cardiotoxicity in breast cancer patients treated with radiation therapy: From evidences to controversies","volume":"156","author":"Loap","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.adro.2025.101931_bib0023","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.3390\/cancers13194790","article-title":"Pertuzumab and trastuzumab combination with concomitant locoregional radiotherapy for the treatment of breast cancers with HER2 receptor overexpression","volume":"13","author":"Aboudaram","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.adro.2025.101931_bib0024","article-title":"Tolerance of concurrent adjuvant radiotherapy and pembrolizumab for triple negative breast cancer: Real life experience","volume":"9","author":"Tison","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101931_bib0025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.prro.2022.02.004","article-title":"Development of simplified auto-segmentable functional cardiac atlas","volume":"12","author":"Loap","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101931_bib0026","doi-asserted-by":"crossref","first-page":"826\u2011833","DOI":"10.1016\/j.canrad.2020.04.012","article-title":"Evaluation of a delineation software for cardiac atlas-based autosegmentation: An example of the use of artificial intelligence in modern radiotherapy","volume":"24","author":"Loap","year":"2020","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.adro.2025.101931_bib0027","doi-asserted-by":"crossref","first-page":"146\u2011154","DOI":"10.1016\/j.radonc.2020.09.044","article-title":"Optimization and auto-segmentation of a high risk cardiac zone for heart sparing in breast cancer radiotherapy","volume":"153","author":"Loap","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2025.101931_bib0028","doi-asserted-by":"crossref","first-page":"13\u201120","DOI":"10.1016\/j.canrad.2020.05.016","article-title":"Evaluating cardiac substructure radiation exposure in breast rotational intensity modulated radiation therapy: Effects of cancer laterality, fractionation and deep inspiration breath-hold","volume":"25","author":"Loap","year":"2021","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.adro.2025.101931_bib0029","doi-asserted-by":"crossref","first-page":"150\u2011158","DOI":"10.1080\/0284186X.2023.2177976","article-title":"Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT)","volume":"62","author":"Loap","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.adro.2025.101931_bib0030","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1080\/0284186X.2021.1907860","article-title":"Cardiac substructure exposure in breast radiotherapy: A comparison between intensity modulated proton therapy and volumetric modulated arc therapy","volume":"60","author":"Loap","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.adro.2025.101931_bib0031","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.canrad.2021.01.005","article-title":"Clinical practice of breast cancer protontherapy: A single-centre experience from selection to treatment","volume":"25","author":"Loap","year":"2021","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.adro.2025.101931_bib0032","first-page":"59\u201164","article-title":"Radiation exposure of cardiac conduction nodes during breast proton therapy","volume":"10","author":"Loap","year":"2023","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.adro.2025.101931_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103574","article-title":"Hadrontherapy techniques for breast cancer","volume":"169","author":"Loap","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.adro.2025.101931_bib0034","doi-asserted-by":"crossref","DOI":"10.1007\/s00066-025-02411-1","article-title":"Proton therapy in young breast cancer patients with germline TP53 and ATM mutations: A case series","author":"Loap","year":"2025","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2025.101931_bib0035","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/bjr\/tqaf049","article-title":"Heart and lung sparing with isocentric lateral decubitus positioning compared with dorsal decubitus positioning during adjuvant localized breast cancer radiotherapy","volume":"98","author":"Loap","year":"2025","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2025.101931_bib0036","doi-asserted-by":"crossref","first-page":"147\u2011152","DOI":"10.1016\/j.clon.2012.07.012","article-title":"Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart","volume":"25","author":"Appelt","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.adro.2025.101931_bib0037","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2019.12.006","article-title":"The limits of the linear quadratic (LQ) model for late cardiotoxicity prediction: Example of hypofractionated rotational intensity modulated radiation therapy (IMRT) for breast cancer","volume":"106","author":"Loap","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2025.101931_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110849","article-title":"Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial","volume":"207","author":"Brion","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2025.101931_bib0039","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1016\/j.ijrobp.2021.07.726","article-title":"Cardiac substructure dose in patients undergoing cardiac-sparing techniques for whole breast radiotherapy or partial breast irradiation: A dosimetric follow-up to IMPORT LOW","volume":"111","author":"Bajaj","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2025.101931_bib0040","doi-asserted-by":"crossref","first-page":"4175\u20114183","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: Long-term results of the randomized phase III APBI-IMRT-Florence trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109425002180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109425002180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:36:10Z","timestamp":1776875770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109425002180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2452109425002180"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2025.101931","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant Radiation Therapy in Breast Cancer Patients With Neurofibromatosis Type 1: Safety and Long-Term Outcomes","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2025.101931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101931"}}